Form 4 Filing for Solid Biosciences Inc. - Officer Stock Transaction

This filing details a Form 4 submission by Kevin Tan, CFO & Treasurer of Solid Biosciences Inc. On January 29, 2026, Mr. Tan was granted 56,647 Restricted Stock Units (RSUs) with a transaction value of $0.00. These RSUs are contingent upon the right to receive one share of the Issuer's common stock. The RSUs are tied to performance milestones, with the second milestone certified as met on January 29, 2026. Vesting is subject to continued service, anticipated in Q1 2027. The transaction code "A" indicates acquisition, and "D" signifies direct ownership.